Evidence map›Paper›PMID 31054106›Full record

ReviewJournal of gastrointestinal cancer2020

Locally Advanced Rectal Cancer Evaluation by Magnetic Resonance Imaging after Neoadjuvant Therapy on Decision Making: Cancer Center Experience and Literature Review.

Alejandro Recio-Boiles, Hytham Hammad, Krisha Howell, Bobby T Kalb, Valentine N Nfonsam, Aaron J Scott, Hani M Babiker, Emad Elquza

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of gastrointestinal cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alejandro Recio-BoilesHematology and Medical Oncology, University of Arizona Cancer Center, 1515 N Campbell Ave, Tucson, AZ, 85724, USA. areciomd@email.arizona.edu.ORCID http://orcid.org/0000-0002-5423-3112
Hytham HammadClinical Research, University of Arizona Cancer Center, Tucson, AZ, USA.
Krisha HowellRadiation Oncology, University of Arizona Cancer Center, Tucson, AZ, USA.
Bobby T KalbMedical Imaging, University of Arizona Cancer Center, Tucson, AZ, USA.
Valentine N NfonsamSurgical Oncology, University of Arizona Cancer Center, Tucson, AZ, USA.
Aaron J ScottHematology and Medical Oncology, University of Arizona Cancer Center, 1515 N Campbell Ave, Tucson, AZ, 85724, USA.
Hani M BabikerHematology and Medical Oncology, University of Arizona Cancer Center, 1515 N Campbell Ave, Tucson, AZ, 85724, USA.
Emad ElquzaHematology and Medical Oncology, University of Arizona Cancer Center, 1515 N Campbell Ave, Tucson, AZ, 85724, USA.
University of Arizona · USBanner - University Medical Center Tucson · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAn accurate clinical and radiological staging is the pyramid of treatment decisions in locally advanced rectal cancer (LARC). Guidelines recommended neoadjuvant chemoradiation therapy (CRT) followed by surgical resection for fit patients with LARC. Determining the aggressiveness of intervention while avoiding needless morbidity according to patient risk remains an unmet pre-operative decision-making need. With newer magnetic resonance imaging (MRI) techniques and image acquisition available at our Cancer Center, we seek to retrospectively review the correlation between pre- and post-CRT MRI response to the surgical pathological stage in order to aide multidisciplinary team decision making.

methodsOur Cancer Center Rectal Cancer Registry between 2011 and 2015 included 57 patients with LARC, 20 completed standard CRT with surgery, and of those 10 had repeated MRI after CRT.

resultsOur retrospective case series revealed that 90% of the patients had a downstage tumor response on surgical specimen compared to radiological evaluation after CRT, and furthermore, all patients who were re-staged with MRI prior to surgery correlated with the gold standard pathological stage (p = 0.02).

conclusionsPost-CRT MRI could potentially aide decision making to further avoid 20% of patients with a complete pathological response from a morbid surgery, whereas 10% of patients with an upstaged disease state may require a more aggressive neoadjuvant or planned surgical intervention. We concluded that future multidisciplinary oncology care treatment decision making would benefit from a repeat MRI after neoadjuvant CRT of LARC.

Indexed as

AdultAgedDecision MakingFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeoadjuvant TherapyRectal NeoplasmsRetrospective StudiesDecision makingLocally advanced rectal cancerMagnetic resonance imagingNeoadjuvant therapy

Identifiers

PMID31054106
OpenAlexW2942735952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.